Keywords
| 1. |
Phillips K, Wright BJ, Kent S. Psychosocial predictors of irritable bowel syndrome diagnosis and symptom severity. J Psychosom Res 2013;75:467-74. ![]() [PUBMED] |
| 2. | |
| 3. |
Wolitzky-Taylor K, Craske MG, Labus JS, Mayer EA, Naliboff BD. Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome. Behav Res Ther 2012;50:647-50. ![]() [PUBMED] |
| 4. |
Burgell RE, Asthana AK, Gibson PR. Irritable bowel syndrome in quiescent inflammatory bowel disease: A review. Minerva Gastroenterol Dietol 2015;61:201-13. ![]() [PUBMED] |
| 5. |
Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006;130:1447-58. ![]() [PUBMED] |
| 6. | |
| 7. |
Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014;264:651-60. ![]() [PUBMED] |
| 8. | |
| 9. | |
| 10. | |
| 11. | |
| 12. |
Peters SL, Muir JG, Gibson PR. Review article: Gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:1104-15. ![]() [PUBMED] |
| 13. | |
| 14. | |
| 15. |
Chilcot J, Moss-Morris R. Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention. Behav Res Ther 2013;51:690-5. ![]() [PUBMED] |
| 16. |
Tang QL, Lin GY, Zhang MQ. Cognitive-behavioral therapy for the management of irritable bowel syndrome. World J Gastroenterol 2013;19:8605-10. ![]() [PUBMED] |
| 17. |
Jang AL, Hwang SK, Kim DU. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: A randomized trial. Eur J Gastroenterol Hepatol 2014;26:918-26. ![]() [PUBMED] |
| 18. |
Li L, Xiong L, Zhang S, Yu Q, Chen M. Cognitive-behavioral therapy for irritable bowel syndrome: A meta-analysis. J Psychosom Res 2014;77:1-2. ![]() [PUBMED] |
| 19. |
Lackner JM, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J, et al. The irritable bowel syndrome outcome study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome. Contemp Clin Trials 2012;33:1293-310. ![]() [PUBMED] |
| 20. | |
| 21. | |
| 22. |
Porcelli P, De Carne M, Leandro G. Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome. Compr Psychiatry 2014;55:1647-53. ![]() [PUBMED] |
| 23. | |
| 24. | |
| 25. | |
| 26. | |
| 27. | |
| 28. | |
| 29. | |
| 30. |
Zorn P, Roder V, Soravia L, Tschacher W. Evaluation of the “Schema-focused emotive behavioural therapy” (SET) for patients with personality disorders: Results of a randomised controlled trial. Psychother Psychosom Med Psychol 2008;58:371-8. ![]() [PUBMED] |
| 31. | |
| 32. | |
| 33. | |
| 34. | |
| 35. |
Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-9. ![]() [PUBMED] |
| 36. | |
| 37. | |
| 38. | |
| 39. | |
| 40. | |
| 41. | |
| 42. | |
| 43. | |
| 44. |